/PRNewswire/ Synthego, a leading provider of genome engineering solutions, and SeQure Dx, a company focused on off-target analysis for preclinical and.
/PRNewswire/ Synthego, a leading provider of genome engineering solutions, today announced the launch of its IND-enabling (INDe) gRNAs, a transformative.
/PRNewswire/ Synthego, a leading provider of industrialized genome editing solutions that accelerate discovery to clinic journey, and bit.bio, the company.
/PRNewswire/ Synthego Corp., a leading genome engineering solutions provider, announced today the launch of its service partner ecosystem, CRISPR Discovery.
/PRNewswire/ Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by.